SciELO - Scientific Electronic Library Online

 
vol.87 número1Diseño de un registro de fibrilación auricular y riesgo embólico en México: CARMEN-AFEuroSCORE subestima el riesgo de mortalidad en cirugía cardiaca valvular de población mexicana índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Archivos de cardiología de México

versión On-line ISSN 1665-1731versión impresa ISSN 1405-9940

Resumen

SANDOVAL ZARATE, Julio et al. Mexican registry of pulmonary hypertension REMEHIP. Arch. Cardiol. Méx. [online]. 2017, vol.87, n.1, pp.13-17. ISSN 1665-1731.  https://doi.org/10.1016/j.acmx.2016.11.006.

Objective:

REMEHIP is a prospective, multicentre registry on pulmonary hypertension. The main objective will be to identify the clinical profile, medical care, therapeutic trends and outcomes in adult and pediatric Mexican patients with well-characterized pulmonary hypertension.

Methods:

REMEHIP a multicenter registry began in 2015 with a planned recruitment time of 12 months and a 4-year follow-up. The study population will comprise a longitudinal cohort study, collecting data on patients with prevalent and incident pulmonary hypertension. Will be included patients of age >2 years and diagnosis of pulmonary hypertension by right heart catheterization within Group 1 and Group 4 of the World Health Organization classification. The structure, data collection and data analysis will be based on quality current recommendations for registries. The protocol has been approved by institutional ethics committees in all participant centers. All patients will sign an informed consent form.

Currently in Mexico, there is a need of observational registries that include patients with treatment in the everyday clinical practice so the data could be validated and additional information could be obtained versus the one from the clinical trials. In this way, REMEHIP emerges as a link among randomized clinical trials developed by experts and previous Mexican experience.

Palabras llave : Pulmonary hypertension; Pulmonary arterial hypertension; Chronic thromboembolic pulmonary hypertension; Registries; Mexico.

        · resumen en Español     · texto en Inglés     · Inglés ( pdf )